KMT2B and Kabuki syndrome: Using similar methodology, we previously found that comparison of methylation profiles in KMT2B NDD individuals (n = 10) and KMT2D associated Kabuki syndrome individuals (n = 10) to control samples (n = 29) identified 1812 and 89 significant DMPs, respectively (5).